Historical Background
The human survivin gene was first cloned and described by Ambrosini et al. in 1997 as a unique and smallest member of inhibitor of apoptosis protein family (IAP) (Ambrosini et al. 1997). IAPs are diverse group of signaling molecules with wide range of physiological role, from the inhibition of apoptosis to cell cycle progression. IAPs have nine family members: X-linked IAP, cIAP1, cIAP2, neuronal apoptosis inhibitor protein, melanoma IAP, IAP-like protein 2, livin, apollon, and survivin. The first IAP was isolated as a baculovirus gene product and identified by the presence of baculovirus IAP repeat (BIR). All the members of IAP family are generally characterized by presence of one or more copies of BIR at N-terminus and ring finger domain at their carboxyl terminus...
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Altieri DC. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene. 2003;22:8581–9. doi:10.1038/sj.onc.1207113.
Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3(8):917–21.
Chen X, Duan N, Zhang C, Zhang W. Survivin and tumorigenesis: molecular mechanisms and therapeutic strategies. J Cancer. 2016;7(3):314–23. doi:10.7150/jca.13332.
Fukuda S, Pelus LM. Survivin, a cancer target with an emerging role in normal adult tissue. Mol Cancer Ther. 2006;5(5):1087–98.
Garg H, Suri P, Gupta JC, Talwar GP, Dubey S. Survivin: a unique target for tumor therapy. Cancer Cell Int. 2016;16:49. doi:10.1186/s12935-016-0326-1.
Jaiswal PK, Goel A, Mittal RD. Survivin: a molecular biomarker in cancer. Indian J Med Res. 2015 Apr;141(4):389–97. doi:10.4103/0971-5916.159250.
Li F. Survivin study: what is the next wave? J Cell Physiol. 2003;197(1):8–29.
Li F. Role of survivin and its splice variants in tumorigenesis. Br J Cancer. 2005;92(2):212–6.
Li F, Yang J, Ramnath N, Javle MM, Tan D. Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer J Int du Cancer. 2005;114(4):509–12. doi:10.1002/ijc.20768.
Mita AC, Mita MM, Nawrocki ST, Giles FJ. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Mol Pathways Clin Cancer Res. 2008;14(16):5000–5. doi:10.1158/1078-0432.CCR-08-0746.
Zhang M, Yang J, Li F. Transcriptional and posttranscriptional controls of survivin in cancer cells: Essential interfaces for developing novel approaches for cancer treatment. J Exp Clin Cancer Res: CR. 2006;25(3):391.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this entry
Cite this entry
Swain, N., Hosalkar, R. (2018). Survivin. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_101998
Download citation
DOI: https://doi.org/10.1007/978-3-319-67199-4_101998
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67198-7
Online ISBN: 978-3-319-67199-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences